Skip to main content
Terug
Watch Compare

Arcturus Therapeutics Holdings Inc.

Datakwaliteit: 100%
ARCT
NASDAQ Manufacturing Chemicals
€ 8,36
▲ € 0,14 (1,70%)
Marktkapitalisatie: 235,34 M
Prijs
€ 8,28
Marktkapitalisatie
235,34 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue grew 60,51% annually over 5 years — strong growth
Negative free cash flow of -74,50 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 106,65%
Capital efficient — spends only 0,28% of revenue on capex

Groei

Revenue Growth (5Y)
60,51%
Boven sectorgemiddelde (1,92%)
Revenue (1Y)-46,14%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-28,88%
Boven sectorgemiddelde (-54,47%)
ROIC-23,47%
Net Margin-80,19%
Op. Margin-92,96%

Veiligheid

Debt / Equity
N/A
Current Ratio7,86
Interest CoverageN/A

Waardering

PE (TTM|NTM)
-3,58 | -1,99
Onder sectorgemiddelde (-1,49)
P/B Ratio1,05
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E -3,6 -1,5
P/B 1,1 1,6
ROE % -28,9 -54,5
Net Margin % -80,2 -41,5
Rev Growth 5Y % 60,5 1,9
D/E — 0,3

Koersdoel Analisten

10 analisten
Buy
Huidig
€ 8,36
+178.7%
Koersdoel
€ 23,30
€ 8,00
€ 20,50
€ 68,00
Vooruitzicht
Forward K/W -1,99
Forward WPA -€ 4,21
Omzet Sch. 44,28 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 4,21
-€ 5,94 – -€ 0,25
 44,28 M 10
FY2026 -€ 4,03
-€ 5,50 – -€ 0,13
 40,22 M 11

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,76 -€ 1,03 -36,4%
Q32025 -€ 0,80 -€ 0,49 +38,7%
Q22025 -€ 0,85 -€ 0,34 +59,8%
Q12025 -€ 1,10 -€ 0,52 +52,7%

ETFs Holding This Stock

ARKG ARKG
1,86% weight
WDNA WDNA
1,67% weight
JSIGX JSIGX
0,94% weight
JSCGX JSCGX
0,94% weight
BBC logo BBC Virtus Biotech Clinical Trials ETF
0,78% weight
JMIGX JMIGX
0,30% weight
JMCGX JMCGX
0,30% weight
NXTE logo NXTE AXS Green Alpha ETF
0,23% weight
GDSRX GDSRX
0,17% weight
GCSCX GCSCX
0,17% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -46,14% Revenue Growth (3Y) -29,87%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 60,51% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 82,03 M Net Income (TTM) -65,78 M
ROE -28,88% ROA -22,24%
Gross Margin N/A Operating Margin -92,96%
Net Margin -80,19% Free Cash Flow (TTM) -74,50 M
ROIC -23,47% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 7,86
Interest Coverage N/A Asset Turnover 0,28
Working Capital 217,50 M Tangible Book Value 224,56 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3,58 Forward P/E -1,99
P/B Ratio 1,05 P/S Ratio 2,87
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 5,32 Fwd Earnings Yield N/A
FCF Yield -31,66%
Market Cap 235,34 M Enterprise Value 54,98 M
Per Share
EPS (Diluted TTM) -2,40 Revenue / Share 2,89
FCF / Share -2,62 OCF / Share -2,61
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,28% FCF Conversion 113,25%
SBC-Adj. FCF -102,59 M Growth Momentum -106,65

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 82,03 M 152,31 M 166,80 M 206,00 M 12,36 M
Net Income -65,78 M -80,94 M -29,73 M 9,35 M -203,67 M
EPS (Diluted) -2,40 -3,00 -1,12 0,35 —
Gross Profit — — — — —
Operating Income -76,26 M -95,67 M -78,21 M 12,18 M -202,85 M
EBITDA — — — — —
R&D Expenses 112,21 M 195,16 M 192,13 M 147,75 M 173,76 M
SG&A Expenses — — — — —
D&A 3,03 M 3,54 M 2,96 M 1,53 M 1,19 M
Interest Expense — — — — —
Income Tax -4.000,0 -4.000,0 1,84 M 1,30 M —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 271,15 M 344,07 M 429,40 M 450,39 M 392,81 M
Total Liabilities 57,16 M 103,09 M 150,89 M 180,08 M 164,60 M
Shareholders' Equity 213,99 M 240,98 M 278,51 M 270,31 M 228,21 M
Total Debt — — — 40,63 M 15,30 M
Cash & Equivalents 230,91 M 237,03 M 292,01 M 391,88 M 370,49 M
Current Assets 241,45 M 305,98 M 386,59 M 403,33 M 378,96 M
Current Liabilities 36,38 M 65,49 M 81,99 M 126,98 M 99,54 M